A. Stenzinger

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology

B. Hutter, M. Fröhlich, S. Uhrig, 2023, NPJ precision oncology.

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

J. Budczies, M. Boerries, S. Lassmann, 2023, NPJ precision oncology.

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer

M. Kriegsmann, A. Stenzinger, D. Kazdal, 2021, Frontiers in Oncology.

Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial

T. Hielscher, K. Kluck, L. Weiss, 2023, Nature communications.

Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary.

S. Riethdorf, H. Wikman, C. Coith, 2024, Clinical chemistry.

Acute expression of human APOBEC3B in mice results in RNA editing and lethality

R. Sotillo, Kálmán Somogyi, B. Stefanovska, 2023, Genome Biology.